Alex Nemiroff Praxis Precision Medicines, Inc. (PRAX) insider trading activity

Alex Nemiroff is General Counsel and Secretary of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 25,932 shares of PRAX, which is worth approximately $4.96 Million. The most recent transaction as insider was on Jan 12, 2026, when has been sold 768 shares (Common Stock) at a price of $275.74 per share, resulting in proceeds of $211,768. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.9K

24.49% 3M change

24.18% 12M change

Total Value Held $4.96 Million

Alex Nemiroff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 12 2026	SELL Payment of exercise price or tax liability	$211,768 $275.74 p/Share	768 Reduced 2.88%	25,932 Common Stock
Jan 10 2026	SELL Payment of exercise price or tax liability	$264,508 $288.45 p/Share	917 Reduced 3.32%	26,700 Common Stock
Jan 08 2026	BUY Grant, award, or other acquisition	-	6,875 Added 19.93%	27,617 Common Stock
Jan 07 2026	SELL Payment of exercise price or tax liability	$26,044 $292.63 p/Share	89 Reduced 0.43%	20,742 Common Stock
Nov 20 2025	SELL Open market or private sale	$4,843,304 $192.73 p/Share	25,130 Reduced 54.68%	20,831 Common Stock
Nov 20 2025	BUY Exercise of conversion of derivative security	$1,825,694 $72.65 p/Share	25,130 Added 35.35%	45,961 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$4,355 $85.4 p/Share	51 Reduced 0.24%	20,831 Common Stock

Jan 12 2025	SELL Payment of exercise price or tax liability	$36,563 $63.15 p/Share	579 Reduced 2.7%	20,882 Common Stock
Jan 10 2025	BUY Grant, award, or other acquisition	-	11,250 Added 34.39%	21,461 Common Stock
Jan 07 2025	SELL Payment of exercise price or tax liability	$6,899 $77.52 p/Share	89 Reduced 0.86%	10,211 Common Stock
Nov 14 2024	SELL Open market or private sale	$660,767 $80.2 p/Share	8,239 Reduced 44.44%	10,300 Common Stock
Nov 14 2024	BUY Exercise of conversion of derivative security	$431,776 $56.94 p/Share	7,583 Added 29.03%	18,540 Common Stock
Jul 29 2024	BUY Grant, award, or other acquisition	-	7,800 Added 41.58%	10,957 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$2,277 $44.65 p/Share	51 Reduced 1.59%	3,157 Common Stock
Jan 07 2024	SELL Payment of exercise price or tax liability	$2,241 $25.19 p/Share	89 Reduced 2.7%	3,208 Common Stock
May 12 2023	BUY Grant, award, or other acquisition	$10,283 $0.88 p/Share	11,686 Added 19.11%	49,460 Common Stock
Feb 12 2023	SELL Payment of exercise price or tax liability	$3,624 $3.94 p/Share	920 Reduced 2.38%	37,774 Common Stock
Jan 07 2023	SELL Payment of exercise price or tax liability	$3,364 $2.52 p/Share	1,335 Reduced 3.34%	38,694 Common Stock
Nov 14 2022	BUY Grant, award, or other acquisition	$1,234 $1.81 p/Share	682 Added 1.68%	40,029 Common Stock
Jun 13 2022	BUY Open market or private purchase	$12,225 $1.63 p/Share	7,500 Added 16.01%	39,347 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	$19,378 $8.8 p/Share	2,202 Added 6.47%	31,847 Common Stock
Feb 12 2022	SELL Payment of exercise price or tax liability	$9,702 $12.85 p/Share	755 Reduced 2.48%	29,645 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	18,000 Added 37.19%	30,400 Common Stock
Feb 12 2021	BUY Grant, award, or other acquisition	-	12,400 Added 50.0%	12,400 Common Stock

Alex Nemiroff

General Counsel and Secretary

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Value

Insider Trading

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Praxis Precision Medicines, Inc.

Track Activities on PRAX

Account